Submitted:
30 December 2025
Posted:
31 December 2025
You are already at the latest version
Abstract
Background/Objectives: Cancer-related cognitive impairment (CRCI) affects 44-75% of cancer survivors, significantly impacting quality of life. While cognitive rehabilitation is recommended as a first-line intervention, implementation remains challenging, with high attrition rates. Acceptability is critical for implementation success yet remains understudied. This study developed and validated the Acceptability of Cognitive Rehabilitation Interventions Survey - Cancer Survivors (ACRIS-CS) and examined prospective acceptability among Portuguese cancer survivors. Methods: A web-based cross-sectional study was conducted with 154 non-central nervous system (non-CNS) cancer survivors (94.8% female; 72.7% breast cancer; mean age 47.28 years, SD = 8.96). Acceptability was assessed using the newly developed 11-item ACRIS-CS, grounded in the Theoretical Framework of Acceptability. Psychometric properties were evaluated through exploratory factor analysis (EFA) and internal consistency. Multiple regression analyses explored factors associated with acceptability. Results: EFA identified three factors explaining 68.70% of the variance: (1) affective attitude and perceived effectiveness, (2) perceived benefits and self-efficacy, and (3) perceived burden. Internal consistency was acceptable (α = 0.85). Survivors reported high prospective acceptability (mean = 67.36/100), with 21.4% scoring above 75. Affective attitude/effectiveness showed the highest ratings (mean = 75.43), whereas perceived burden was moderate (mean = 49.35). Being in active treatment and having prior knowledge of CRCI predicted higher acceptability (R² adjusted = 0.113). Conclusions: The ACRIS-CS is a valid and reliable measure of prospective acceptability for cognitive rehabilitation among cancer survivors. High acceptability indicates strong receptivity, while concerns about burden highlight the need for flexible delivery formats. By identifying survivors who may be less receptive before treatment begins, the ACRIS-CS can support the integration of cognitive rehabilitation into survivorship care and inform tailored strategies—such as targeted psychoeducation—to enhance adherence and improve clinical outcomes.
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design, Participants, and Recruitment
2.2. Measures
2.2.1. Sociodemographic and Clinical Characteristics
2.2.2. Anxiety and Depressive Symptoms
2.2.3. Cognitive Symptoms
2.2.4. Knowledge of CRCI
2.2.5. Acceptability of Cognitive Rehabilitation: ACRIS-CS
2.3. Data Analysis
3. Results
3.1. Sample Characteristics
3.2. ACRIS-CS Item Descriptives
3.3. Psychometric Properties of ACRIS-CS
3.3.1. Item Properties
3.3.2. Structural Validity: Exploratory Factor Analysis
3.3.3. Reliability: Internal Consistency
3.4. Acceptability of Cognitive Rehabilitation
3.5. Factors that Influence the Acceptability of Cognitive Rehabilitation
4. Discussion
4.1. Limitations
4.2. Implications and Future Research
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| ACRIS-CS | Acceptability of Cognitive Rehabilitation Interventions Survey for Cancer Survivors |
| CNS | Central nervous system |
| CogPCI FACT-Cog-v3 | Perceived Cognitive Impairment subscale of the Functional Assessment of Cancer Therapy-Cognitive Function-Version 3 |
| CRCI | Cancer-related cognitive impairment |
| EFA | Exploratory factor analysis |
| HADS | Hospital Anxiety and Depression Scale |
| IQR | Interquartile ranges |
| KMO | Kaiser-Meyer-Olkin |
| PCA | Principal component analysis |
| SD | Standard deviation |
| TFA | Theoretical Framework of Acceptability |
| WHO | World Health Organization |
Appendix A
Appendix A.1. European Portuguese Version of the ACRIS-CS
| Discordo fortemente | Discordo | Neutro(a) | Concordo | Concordo fortemente | ||
| 1 | Sinto que a participação num programa de reabilitação cognitiva seria positiva para mim | |||||
| 2 | Reconheço que a participação em programas de reabilitação cognitiva iria melhorar as minhas funções cognitivas | |||||
| 3 | A participação num programa de reabilitação cognitiva seria útil para lidar com as minhas dificuldades cognitivas | |||||
| 4 | Teria facilidade em integrar na minha rotina diária a realização de exercícios de treino cognitivo entre as sessões de um programa de reabilitação cognitiva | |||||
| 5 | Sinto que a participação num programa de reabilitação cognitiva iria comprometer a minha rotina diária | |||||
| 6 | Teria facilidade em integrar na minha rotina diária a participação num programa de reabilitação cognitiva | |||||
| 7 | Os programas de reabilitação cognitiva seriam eficazes para resolver/melhorar as minhas dificuldades cognitivas | |||||
| 8 | Tenho confiança de que seria capaz de realizar todas as tarefas de um programa de reabilitação cognitiva | |||||
| 9 | A participação num programa de reabilitação cognitiva não iria colidir com as minhas crenças e valores | |||||
| 10 | Os programas de reabilitação cognitiva seriam uma opção de intervenção atrativa para mim | |||||
| 11 | Participar num programa de reabilitação cognitiva exigiria de mim muito tempo e energia |
- Inverter a cotação dos itens 5 e 11 (1 → 5, 2 → 4, 3 → 3, 4 → 2, 5 → 1)
-
Calcular as pontuações das subescalas:
- Fator 1 (Atitude Afetiva e Eficácia): Pontuação média dos itens 1, 2, 3, 7, 9 e 10
- Fator 2 (Benefícios Percecionados e Autoeficácia): Pontuação média dos itens 4, 6 e 8
- Fator 3 (Sobrecarga Percecionada): Pontuação média dos itens 5R e 11R
- Calcular a pontuação total: Pontuação média de todos os 11 itens (após inversão da cotação)
- Padronizar para escala 0-100: ((pontuação – 1) / 4) × 100
Appendix A.2. English Translated Version of the ACRIS-CS [Free Translation, Not Validated]
| Totally disagree | Disagree | Neutral | Agree | Totally agree | ||
| 1 | I feel that participation in a cognitive rehabilitation program would be positive for me | |||||
| 2 | I recognize that participation in cognitive rehabilitation programs would improve my cognitive functions | |||||
| 3 | Participation in a cognitive rehabilitation program would help address my cognitive difficulties | |||||
| 4 | I would easily integrate cognitive training exercises into my daily routine between sessions of a cognitive rehabilitation program | |||||
| 5 | I feel that participating in a cognitive rehabilitation program would compromise my daily routine | |||||
| 6 | I would easily integrate participation in a cognitive rehabilitation program into my daily routine | |||||
| 7 | Cognitive rehabilitation programs would be effective in resolving/improving my cognitive difficulties | |||||
| 8 | I am confident that I would be able to perform all tasks in a cognitive rehabilitation program | |||||
| 9 | Participation in a cognitive rehabilitation program would not conflict with my beliefs and values | |||||
| 10 | Cognitive rehabilitation programs would be an attractive intervention option for me | |||||
| 11 | Participating in a cognitive rehabilitation program would require a lot of time and energy from me |
- Reverse-score items 5 and 11 (1 → 5, 2 → 4, 3 → 3, 4 → 2, 5 → 1)
-
Calculate subscale scores:
- Factor 1 (Affective Attitude and Effectiveness): Average score of items 1, 2, 3, 7, 9, and 10
- Factor 2 (Perceived Benefits and Self-Efficacy): Average score of items 4, 6, and 8
- Factor 3 (Perceived Burden): Average score of items 5R and 11R
- Calculate total score: Average score of all 11 items (after reverse-scoring)
- Standardize to 0-100: ((score – 1) / 4) x 100
References
- Boykoff, N.; Moieni, M.; Subramanian, S.K. Confronting Chemobrain: An in-Depth Look at Survivors’ Reports of Impact on Work, Social Networks, and Health Care Response. Journal of Cancer Survivorship 2009, 3, 223–232. [Google Scholar] [CrossRef] [PubMed]
- Gaynor, A.M.; Root, J.C.; Ahles, T.A. Neuropsychological Impact of Cancer and Cancer Treatments. In Psycho-Oncology (Fourth Edition); Breitbart, W.S., Butow, P.N., Jacobsen, P.B., Lam, W.W.T., Lazenby, M., Loscalzo, M.J., Eds.; Oxford University Press: New York, NY, 2021; pp. 283–290. [Google Scholar]
- Haywood, D.; Dauer, E.; Baughman, F.D.; Lawrence, B.J.; Rossell, S.L.; Hart, N.H.; O’Connor, M. “Is My Brain Ever Going to Work Fully Again?”: Challenges and Needs of Cancer Survivors with Persistent Cancer-Related Cognitive Impairment. Cancers (Basel) 2023, 15, 5331. [Google Scholar] [CrossRef]
- Staat, K.; Segatore, M. The Phenomenon of Chemo Brain. Clin J Oncol Nurs 2005, 9, 713–721. [Google Scholar] [CrossRef]
- Bernstein, L.J.; McCreath, G.A.; Komeylian, Z.; Rich, J.B. Cognitive Impairment in Breast Cancer Survivors Treated with Chemotherapy Depends on Control Group Type and Cognitive Domains Assessed: A Multilevel Meta-Analysis. Neurosci Biobehav Rev 2017, 83, 417–428. [Google Scholar] [CrossRef]
- Horowitz, T.S.; Treviño, M.; Gooch, I.M.; Duffy, K.A. Understanding the Profile of Cancer-Related Cognitive Impairments: A Critique of Meta-Analyses. J Natl Cancer Inst 2019, 111, djz100. [Google Scholar] [CrossRef] [PubMed]
- Dijkshoorn, A.B.C.; van Stralen, H.E.; Sloots, M.; Schagen, S.B.; Visser-Meily, J.M.A.; Schepers, V.P.M. Prevalence of Cognitive Impairment and Change in Patients with Breast Cancer: A Systematic Review of Longitudinal Studies. Psychooncology 2021, 30, 635–648. [Google Scholar] [CrossRef]
- Mayo, S.J.; Lustberg, M.; Dhillon, H.M.; Nakamura, Z.M.; Allen, D.H.; Ah, D.; Janelsins, M.C.; Chan, A.; Olson, K.; Chia, J.T.; et al. Cancer-Related Cognitive Impairment in Patients with Non-Central Nervous System Malignancies: An Overview for Oncology Providers from the MASCC Neurological Complications Study Group. Supportive Care in Cancer 2021, 29, 2821–2840. [Google Scholar] [CrossRef]
- Whittaker, A.L.; George, R.P.; O’Malley, L. Prevalence of Cognitive Impairment Following Chemotherapy Treatment for Breast Cancer: A Systematic Review and Meta-Analysis. Sci Rep 2022, 12, 2135. [Google Scholar] [CrossRef]
- Di Iulio, F.; Cravello, L.; Shofany, J.; Paolucci, S.; Caltagirone, C.; Morone, G. Neuropsychological Disorders in Non-Central Nervous System Cancer: A Review of Objective Cognitive Impairment, Depression, and Related Rehabilitation Options. Neurological Sciences 2019, 40, 1759–1774. [Google Scholar] [CrossRef] [PubMed]
- Collins, B.; MacKenzie, J.; Tasca, G.A.; Scherling, C.; Smith, A. Persistent Cognitive Changes in Breast Cancer Patients 1 Year Following Completion of Chemotherapy. Journal of the International Neuropsychological Society 2014, 20, 370–379. [Google Scholar] [CrossRef]
- Koppelmans, V.; Breteler, M.M.B.; Boogerd, W.; Seynaeve, C.; Gundy, C.; Schagen, S.B. Neuropsychological Performance in Survivors of Breast Cancer More than 20 Years after Adjuvant Chemotherapy. Journal of Clinical Oncology 2012, 30, 1080–1086. [Google Scholar] [CrossRef]
- Oliveira, A.F.; Marques-Fernandes, S.A.; Bártolo, A.; Bem-Haja, P.; Torres, A.; Santos, I.M. Establishing Diagnostic Cut-off Scores for the Perceived Cognitive Impairment Subscale of the Functional Assessment of Cancer Therapy-Cognitive Function—Version 3 in Portuguese Cancer Survivors. Psychooncology 2025, 34, e70278. [Google Scholar] [CrossRef]
- Sleurs, C.; Amidi, A.; Wu, L.M.; Kiesl, D.; Zimmer, P.; Lange, M.; Rogiers, A.; Giffard, B.; Binarelli, G.; Borghgraef, C.; et al. Cancer-Related Cognitive Impairment in Non-CNS Cancer Patients: Targeted Review and Future Action Plans in Europe. Crit Rev Oncol Hematol 2022, 180, 103859. [Google Scholar] [CrossRef]
- Haywood, D.; Henry, M.; Dauer, E.; Lederman, O.; Farley, M.; Henneghan, A.M.; O’Connor, M.; Jefford, M.; Rossell, S.L.; Hart, N.H. Cancer-Related Cognitive Impairment as a Key Contributor to Psychopathology in Cancer Survivors: Implications for Prevention, Treatment and Supportive Care. Supportive Care in Cancer 2024, 32, 480. [Google Scholar] [CrossRef] [PubMed]
- Myers, J.S. Chemotherapy-Related Cognitive Impairment - The Breast Cancer Experience. Oncol Nurs Forum 2012, 39, E31–E40. [Google Scholar] [CrossRef] [PubMed]
- Selamat, M.H.; Loh, S.Y.; Mackenzie, L.; Vardy, J. Chemobrain Experienced by Breast Cancer Survivors: A Meta-Ethnography Study Investigating Research and Care Implications. PLoS One 2014, 9, e108002. [Google Scholar] [CrossRef]
- Von Ah, D.; Storey, S.; Tallman, E.; Nielsen, A.; Johns, S.A.; Pressler, S.J. Cancer, Cognitive Impairment, and Work-Related Outcomes: An Integrative Review. Oncol Nurs Forum 2016, 43, 602–616. [Google Scholar] [CrossRef]
- Crouch, A.; Von Ah, D.; Storey, S. Addressing Cognitive Impairment after Breast Cancer: What Do Women Want? Clinical Nurse Specialist 2017, 31, 82–88. [Google Scholar] [CrossRef]
- Hart, N.H.; Stout, N.L.; Haywood, D.; Ashbury, F.D.; Chan, R.J.; Fitch, M.I.; Jefford, M.; Lustberg, M.B.; Etemadi, Y.; Rauch, A. World Health Organization Package of Interventions for Rehabilitation for Cancer: A MASCC-Endorsed Resource for Global Action to Address Unmet Rehabilitation Needs of People Affected by Cancer. Supportive Care in Cancer 2024, 32, 417. [Google Scholar] [CrossRef] [PubMed]
- Cheng, A.S.K.; Wang, X.; Niu, N.; Liang, M.; Zeng, Y. Neuropsychological Interventions for Cancer-Related Cognitive Impairment: A Network Meta-Analysis of Randomized Controlled Trials. Neuropsychol Rev 2022, 32, 893–905. [Google Scholar] [CrossRef]
- Haywood, D.; Henneghan, A.M.; Chan, A.; Chan, R.J.; Dhillon, H.M.; Lustberg, M.B.; Vardy, J.L.; O’Connor, M.; Elvidge, N.; Dauer, E.; et al. The Effect of Non-Pharmacological Interventions on Cognitive Function in Cancer: An Overview of Systematic Reviews. Supportive Care in Cancer 2025, 33, 151. [Google Scholar] [CrossRef] [PubMed]
- Pike, K.E.; Li, L.; Naismith, S.L.; Bahar-Fuchs, A.; Lee, A.; Mehrani, I.; Bentvelzen, A.; Lautenschlager, N.T.; O’Connell, M.E.; Blackberry, I.; et al. Implementation of Cognitive (Neuropsychological) Interventions for Older Adults in Clinical or Community Settings: A Scoping Review. Neuropsychol Rev 2025, 35, 588–616. [Google Scholar] [CrossRef] [PubMed]
- Treanor, C.J.; Mcmenamin, U.C.; O’Neill, R.F.; Cardwell, C.R.; Clarke, M.J.; Cantwell, M.; Donnelly, M. Non-Pharmacological Interventions for Cognitive Impairment Due to Systemic Cancer Treatment (Review). Cochrane Database of Systematic Reviews 2016, CD011325. [Google Scholar] [CrossRef]
- Zeng, Y.; Dong, J.; Huang, M.; Zhang, J. e.; Zhang, X.; Xie, M.; Wefel, J.S. Nonpharmacological Interventions for Cancer-Related Cognitive Impairment in Adult Cancer Patients: A Network Meta-Analysis. Int J Nurs Stud 2020, 104, 103514. [Google Scholar] [CrossRef]
- Duivon, M.; Lange, M.; Binarelli, G.; Lefel, J.; Hardy-Léger, I.; Kiasuwa-Mbengi, R.; Méric, J.B.; Charles, C.; Joly, F. Improve the Management of Cancer-Related Cognitive Impairment in Clinical Settings: A European Delphi Study. Journal of Cancer Survivorship 2024, 18, 1974–1997. [Google Scholar] [CrossRef]
- Nakamura, Z.M.; Ali, N.T.; Crouch, A.; Dhillon, H.; Federico, A.; Gates, P.; Grech, L.; Kesler, S.R.; Ledbetter, L.; Mantovani, E.; et al. Impact of Cognitive Rehabilitation on Cognitive and Functional Outcomes in Adult Cancer Survivors: A Systematic Review. Semin Oncol Nurs 2024, 40, 151696. [Google Scholar] [CrossRef]
- Yang, P.; Hu, Q.; Zhang, L.; Shen, A.; Zhang, Z.; Wang, Q.; Lu, Q. Effects of Non-Pharmacological Interventions on Cancer-Related Cognitive Impairment in Patients with Breast Cancer: A Systematic Review and Network Meta-Analysis. European Journal of Oncology Nursing 2025, 75, 102804. [Google Scholar] [CrossRef]
- National Comprehensive Cancer Network. NCCN Guidelines Version 2.2025 Survivorship. Available online: https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1466#:~:text=Guidelines-,NCCN%20Guidelines,-Version%202.2025 (accessed on 1 November 2025).
- Antares Consulting and Unicancer; Sciensano. Guide: Practices and Recommendations for the Management of Cognitive Impairment after Cancer. Available online: https://www.ipaac.eu/res/file/outputs/wp4/practices-recommendations-cancer-cognitive-impairements.pdf (accessed on 1 November 2025).
- Binarelli, G.; Duivon, M.; Joly, F.; Ahmed-Lecheheb, D.; Lange, M. Cancer-Related Cognitive Impairment: Current Perspectives on the Management of Cognitive Changes Following Cancer Treatment. Expert Rev Neurother 2023, 23, 249–268. [Google Scholar] [CrossRef]
- Clare, L.; Woods, R.T. Cognitive Training and Cognitive Rehabilitation for People with Early-Stage Alzheimer’s Disease: A Review. Neuropsychological Rehabilitation: An International Journal 2004, 14, 385–401. [Google Scholar] [CrossRef]
- Fernandes, H.A.; Richard, N.M.; Edelstein, K. Cognitive Rehabilitation for Cancer-Related Cognitive Dysfunction: A Systematic Review. Supportive Care in Cancer 2019, 27, 3253–3279. [Google Scholar] [CrossRef] [PubMed]
- Yan, X.; Wei, S.; Liu, Q. Effect of Cognitive Training on Patients with Breast Cancer Reporting Cognitive Changes: A Systematic Review and Meta-Analysis. BMJ Open 2023, 13, e058088. [Google Scholar] [CrossRef]
- Oliveira, A.F.; Sosa-Napolskij, M.; Torres, A.; Queiroz, D.F.; Bártolo, A.; Sousa, H.; Monteiro, S.; Van Dyk, K.; Ercoli, L.M.; Santos, I.M. CanCOG®: Cultural Adaptation of the Evidence-Based UCLA Cognitive Rehabilitation Intervention Program for Cancer Survivors in Portugal. Healthcare 2023, 11, 141. [Google Scholar] [CrossRef]
- Proctor, E.; Silmere, H.; Raghavan, R.; Hovmand, P.; Aarons, G.; Bunger, A.; Griffey, R.; Hensley, M. Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda. Administration and Policy in Mental Health and Mental Health Services Research 2011, 38, 65–76. [Google Scholar] [CrossRef]
- Sekhon, M.; Cartwright, M.; Francis, J.J. Acceptability of Healthcare Interventions: An Overview of Reviews and Development of a Theoretical Framework. BMC Health Serv Res 2017, 17, 88. [Google Scholar] [CrossRef]
- Skivington, K.; Matthews, L.; Simpson, S.A.; Craig, P.; Baird, J.; Blazeby, J.M.; Boyd, K.A.; Craig, N.; French, D.P.; McIntosh, E.; et al. A New Framework for Developing and Evaluating Complex Interventions: Update of Medical Research Council Guidance. The BMJ 2021, 374, n2061. [Google Scholar] [CrossRef]
- Sekhon, M.; Cartwright, M.; Francis, J.J. Acceptability of Health Care Interventions: A Theoretical Framework and Proposed Research Agenda. Br J Health Psychol 2018, 23, 519–531. [Google Scholar] [CrossRef]
- Sekhon, M.; Cartwright, M.; Lawes-Wickwar, S.; McBain, H.; Ezra, D.; Newman, S.; Francis, J.J. Does Prospective Acceptability of an Intervention Influence Refusal to Participate in a Randomised Controlled Trial? An Interview Study. Contemp Clin Trials Commun 2021, 21, 100698. [Google Scholar] [CrossRef] [PubMed]
- Gonzalez, J.M.; Alegría, M.; Prihoda, T.J.; Copeland, L.A.; Zeber, J.E. How the Relationship of Attitudes toward Mental Health Treatment and Service Use Differs by Age, Gender, Ethnicity/Race and Education. Soc Psychiatry Psychiatr Epidemiol 2011, 46, 45–57. [Google Scholar] [CrossRef] [PubMed]
- Pedro, L.M.R.; de Oliveira, M.F.; Pereira, M.D.; da Fonseca, A.D.; Canavarro, M.C. Factors Associated with Prospective Acceptability and Preferences for Unified Transdiagnostic Cognitive-Behavioral Treatments and Group Therapy in the Portuguese General Population. Administration and Policy in Mental Health and Mental Health Services Research 2024, 51, 857–876. [Google Scholar] [CrossRef] [PubMed]
- Young, B.; Robb, K.A. Understanding Patient Factors to Increase Uptake of Cancer Screening: A Review. Future Oncology 2021, 17, 3757–3775. [Google Scholar] [CrossRef]
- Hewitt, M.; Greenfield, S.; Stovall, E. From Cancer Patient to Cancer Survivor: Lost in Transition; The National Academies Press: Washington, D.C., 2006; ISBN 978-0-309-09595-2. [Google Scholar]
- Mollica, M.A.; Doose, M.; Reed, C.; Tonorezos, E. Defining Concepts in Cancer Survivorship. Cancer 2025, e70039. [Google Scholar] [CrossRef]
- Buchanan, N.D.; Dasari, S.; Rodriguez, J.L.; Lee Smith, J.; Hodgson, M.E.; Weinberg, C.R.; Sandler, D.P. Post-Treatment Neurocognition and Psychosocial Care among Breast Cancer Survivors. Am J Prev Med 2015, 49, S498–S508. [Google Scholar] [CrossRef] [PubMed]
- Lange, M.; Licaj, I.; Clarisse, B.; Humbert, X.; Grellard, J.-M.; Tron, L.; Joly, F. Cognitive Complaints in Cancer Survivors and Expectations for Support: Results from a Web–Based Survey. Cancer Med 2019, 8, 2654–2663. [Google Scholar] [CrossRef]
- World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA 2025, 333, 71–74. [Google Scholar] [CrossRef]
- American Psychological Association. Publication Manual of the American Psychological Association, Seventh Edition; American Psychological Association, Ed.; 2020.
- Ordem dos Psicólogos Portugueses. Regulamento n.o 898/2024, Código Deontológico Da Ordem Dos Psicólogos Portugueses (OPP); 2024.
- LimeSurvey GmbH LimeSurvey: An Open Source Survey Tool. Available online: https://www.limesurvey.org/ (accessed on 29 December 2025).
- Pais-Ribeiro, J.; Silva, I.; Ferreira, T.; Martins, A.; Meneses, R.; Baltar, M. Validation Study of a Portuguese Version of the Hospital Anxiety and Depression Scale. Psychol Health Med 2007, 12, 225–237. [Google Scholar] [CrossRef]
- Zigmond, A.S.; Snaith, R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983, 67, 361–370. [Google Scholar] [CrossRef]
- Wagner, L.I.; Sweet, J.; Butt, Z.; Lai, J.; Cella, D. Measuring Patient Self-Reported Cognitive Function: Development of the Functional Assessment of Cancer Therapy-Cognitive Function Instrument. J Support Oncol 2009, 7, 32–39. [Google Scholar]
- Oliveira, A.F.; Santos, I.M.; Fernandes, S.; Bem-Haja, P.; Torres, A. Validation Study of the Functional Assessment of Cancer Therapy-Cognitive Function-Version 3 for the Portuguese Population. BMC Psychol 2022, 10, 305. [Google Scholar] [CrossRef] [PubMed]
- Schagen, S.B.; Das, E.; Vermeulen, I. Information about Chemotherapy-Associated Cognitive Problems Contributes to Cognitive Problems in Cancer Patients. Psychooncology 2012, 21, 1132–1135. [Google Scholar] [CrossRef] [PubMed]
- Schagen, S.B.; Das, E.; van Dam, F.S.A.M. The Influence of Priming and Pre-Existing Knowledge of Chemotherapy-Associated Cognitive Complaints on the Reporting of Such Complaints in Breast Cancer Patients. Psychooncology 2009, 18, 674–678. [Google Scholar] [CrossRef] [PubMed]
- Timm, L.; Annerstedt, K.S.; Ahlgren, J.Á.; Absetz, P.; Alvesson, H.M.; Forsberg, B.C.; Daivadanam, M. Application of the Theoretical Framework of Acceptability to Assess a Telephone-Facilitated Health Coaching Intervention for the Prevention and Management of Type 2 Diabetes. PLoS One 2022, 17, e0275576. [Google Scholar] [CrossRef]
- Boateng, G.O.; Neilands, T.B.; Frongillo, E.A.; Melgar-Quiñonez, H.R.; Young, S.L. Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer. Front Public Health 2018, 6, 149. [Google Scholar] [CrossRef]
- Fonseca, A.; Gorayeb, R.; Canavarro, M.C. Women’s Use of Online Resources and Acceptance of e-Mental Health Tools during the Perinatal Period. Int J Med Inform 2016, 94, 228–236. [Google Scholar] [CrossRef]
- Sousa, M.; Moreira, H.; Canavarro, M.C.; Barreto Carvalho, C. Estudo de Aceitabilidade Das Intervenções Psicológicas via Telefone Para Sobreviventes de Cancro Dos Açores [Azorean Cancer Survivors’ Acceptability of Psychological Telephone-Based Interventions]. Revista Psicologia, Diversidade e Saúde 2021, 10, 37–56. [Google Scholar] [CrossRef]
- Mokkink, L.B.; Terwee, C.B.; Patrick, D.L.; Alonso, J.; Stratford, P.W.; Knol, D.L.; Bouter, L.M.; De Vet, H.C.W. The COSMIN Checklist for Assessing the Methodological Quality of Studies on Measurement Properties of Health Status Measurement Instruments: An International Delphi Study. Quality of Life Research 2010, 19, 539–549. [Google Scholar] [CrossRef] [PubMed]
- Kaiser, H.F. An Index of Factorial Simplicity. Psychometrika 1974, 39, 31–36. [Google Scholar] [CrossRef]
- Bartlett, M.S. Tests of Significance in Factor Analysis. British Journal of Statistical Psychology 1950, 3, 77–85. [Google Scholar] [CrossRef]
- Costello, A.B.; Osborne, J.W. Best Practices in Exploratory Factor Analysis: Four Recommendations for Getting the Most from Your Analysis. Practical Assessment, Research & Evaluation 2005, 10, 1–9. [Google Scholar] [CrossRef]
- Kaiser, H.F. The Application of Electronic Computers to Factor Analysis. Educ Psychol Meas 1960, 20, 141–151. [Google Scholar] [CrossRef]
- Cattell, R.B. The Scree Test for the Number of Factors. Multivariate Behav Res 1966, 1, 245–276. [Google Scholar] [CrossRef]
- Fayers, P.M.; Machin, D. Quality of Life: The Assessment, Analysis and Reporting of Patient-Reported Outcomes; Third Edition; John Wiley & Sons, Ltd.: Oxford, 2016. [Google Scholar]
- Nunnally, J.C.; Bernstein, I.H. Psychometric Theory (Third Edition); McGraw-Hill, Inc.: New York, 1994. [Google Scholar]
- Kaur, P.; Stoltzfus, J.; Yellapu, V. Descriptive Statistics. Int J Acad Med 2018, 4, 60–63. [Google Scholar] [CrossRef]
- Cohen, J. Statistical Power Analysis for the Behavioral Sciences (Second Edition); Lawrence Erlbaum Associates: New York, 1988. [Google Scholar]
- George, D.; Mallery, P. IBM SPSS Statistics 29 Step by Step: A Simple Guide and Reference (Eighteenth Edition); Routledge: New York, NY, 2024. [Google Scholar]
- De Vet, H.C.W.; Terwee, C.B.; Mokkink, L.B.; Knol, D.L. Measurement in Medicine: A Practical Guide; Cambridge University Press: New York, 2011. [Google Scholar]
- Chen, Y.-X.; Zhou, Y.; Zhang, X.-L.; He, W.; Ye, Q.; Xu, M. Digital Health Interventions for Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Scoping Review. Digit Health 2025, 11, 1–23. [Google Scholar] [CrossRef]
- Kim, Y.; Kang, S.J. Computerized Programs for Cancer Survivors with Cognitive Problems: A Systematic Review. Journal of Cancer Survivorship 2019, 13, 911–920. [Google Scholar] [CrossRef]
- Wang, Y.; Zhang, Y.; Li, R.; Sun, Z.; Li, Q. Web-Based Cognitive Interventions on Subjective Cognitive Impairment in Cancer Survivors: A Systemic Review. Int J Nurs Sci 2024, 11, 429–438. [Google Scholar] [CrossRef] [PubMed]
- Merceur, M.; Reilly, K.T.; Bonan, I.; Holé, J.; Hummel, E.; Cogné, M.; Jacquin-Courtois, S. A Systematic Review of Rehabilitation Programs for Cognitive Impairment Related to Breast Cancer: Different Programs at Different Times? Ann Phys Rehabil Med 2024, 67, 101832. [Google Scholar] [CrossRef] [PubMed]

| Characteristics | N | n | % |
|---|---|---|---|
| Age at enrolment in years (M ± SD; range) | 154 | 47.28 ± 8.96; 18-65 | |
| Sex | 154 | ||
| Male | 8 | 5.2 | |
| Female | 146 | 94.8 | |
| Marital status | 154 | ||
| Married/de facto relationship | 108 | 70.1 | |
| Single | 24 | 15.6 | |
| Divorced/separated | 18 | 11.7 | |
| Widowed | 4 | 2.6 | |
| Education level | 152 | ||
| Primary school (completed or unfinished) | 7 | 4.6 | |
| Middle school | 12 | 7.9 | |
| High school | 36 | 23.7 | |
| University | 97 | 63.8 | |
| Employment status | 151 | ||
| Employed/Self-employed (full- or part-time) | 93 | 61.6 | |
| Unemployed | 17 | 11.3 | |
| Sick leave | 29 | 19.2 | |
| Retired | 10 | 6.6 | |
| Student | 2 | 1.3 | |
| Type of cancer | 154 | ||
| Breast | 112 | 72.7 | |
| Ovarian | 8 | 5.2 | |
| Colorectal | 7 | 4.5 | |
| Leukemia | 2 | 1.3 | |
| Hodgkin Lymphoma | 7 | 4.5 | |
| Non-Hodgkin Lymphoma | 6 | 3.9 | |
| Other 1 | 12 | 7.6 | |
| Cancer staging | 154 | ||
| Localized cancer (stages 0, I, II) | 74 | 48.1 | |
| Non-localized cancer (stages III, IV) | 59 | 38.3 | |
| Unknown information | 21 | 13.6 | |
| Time since diagnosis in years (M ± SD; range) | 154 | 5.70 ± 6.16; 1-48 | |
| Cancer treatment history | 154 | ||
| Surgery | 123 | 79.9 | |
| Chemotherapy | 137 | 89.0 | |
| Radiotherapy | 106 | 68.8 | |
| Hormone therapy | 82 | 53.2 | |
| Immunotherapy | 26 | 16.9 | |
| Targeted therapy | 10 | 6.5 | |
| Stem cell transplant | 3 | 1.9 | |
| Current stage of the cancer treatment | 154 | ||
| Undergoing treatment | 76 | 49.4 | |
| Follow-up | 78 | 50.6 | |
| Current cancer treatment | 76 | ||
| Chemotherapy | 9 | 11.8 | |
| Radiotherapy | 4 | 5.3 | |
| Hormone therapy | 52 | 68.4 | |
| Immunotherapy | 13 | 17.1 | |
| Targeted therapy | 3 | 3.9 | |
| Psychological counseling (previous or current) (Yes) | 154 | 91 | 59.1 |
| Currently taking psychotropic medication 2 (Yes) | 154 | 70 | 45.5 |
| Psychological distress (HADS) | 117 | ||
| Anxiety (M ± SD; range) | 10.01 ± 4.24; 2-21 | ||
| Depression (M ± SD; range) | 6.86 ± 4.04; 0-19 | ||
| Perceived cognitive impairment (CogPCI FACT-Cog-v3) (M ± SD; range) | 118 | 37.76 ± 16.83; 3-76 | |
| Knowledge of CRCI | 154 | ||
| No, not at all [familiar] | 11 | 7.1 | |
| Slightly [familiar] | 51 | 33.1 | |
| Neutral | 17 | 11.0 | |
| Yes, [familiar] | 56 | 36.4 | |
| Totally [familiar] | 19 | 12.3 | |
| Item | Totally disagree 1 | Disagree 1 | Neutral 1 | Agree 1 | Totally agree 1 | Mdn (IQR) |
|---|---|---|---|---|---|---|
| 1 | 0 (0) | 0 (0) | 21 (13.6) | 90 (58.4) | 43 (27.9) | 3 (1) |
| 2 | 0 (0) | 1 (0.6) | 26 (16.9) | 87 (56.5) | 40 (26) | 3 (1) |
| 3 | 0 (0) | 1 (0.6) | 17 (11) | 95 (61.7) | 41 (26.6) | 3 (1) |
| 4 | 2 (1.3) | 14 (9.1) | 43 (27.9) | 82 (53.2) | 13 (8.4) | 3 (1) |
| 5 | 10 (6.5) | 37 (24) | 50 (32.5) | 50 (32.5) | 7 (4.5) | 2 (2) |
| 6 | 2 (1.3) | 21 (13.6) | 58 (37.7) | 61 (39.6) | 12 (7.8) | 2 (1) |
| 7 | 0 (0) | 0 (0) | 37 (24) | 93 (60.4) | 24 (15.6) | 3 (0) |
| 8 | 1 (0.6) | 5 (3.2) | 59 (38.3) | 77 (50) | 12 (7.8) | 3 (1) |
| 9 | 5 (3.2) | 9 (5.8) | 23 (14.9) | 73 (47.4) | 44 (28.6) | 3 (1) |
| 10 | 0 (0) | 2 (1.3) | 37 (24) | 89 (57.8) | 26 (16.9) | 3 (1) |
| 11 | 2 (1.3) | 52 (33.8) | 64 (41.6) | 31 (20.1) | 5 (3.2) | 2 (1) |
| Item | Min-Max | Skewness | Kurtosis | Corrected Item-Total Correlation | Cronbach’s Alpha If Item Deleted |
|---|---|---|---|---|---|
| 1 | 2-4 | -0.120 | -0.522 | 0.704 | 0.815 |
| 2 | 1-4 | -0.223 | -0.302 | 0.662 | 0.817 |
| 3 | 1-4 | -0.268 | 0.259 | 0.673 | 0.817 |
| 4 | 0-4 | -0.668 | 0.469 | 0.531 | 0.826 |
| 5 | 0-4 | -0.209 | -0.646 | 0.381 | 0.843 |
| 6 | 0-4 | -0.236 | -0.225 | 0.670 | 0.813 |
| 7 | 2-4 | 0.061 | -0.435 | 0.624 | 0.821 |
| 8 | 0-4 | -0.286 | 0.593 | 0.429 | 0.834 |
| 9 | 0-4 | -1.065 | 1.085 | 0.255 | 0.855 |
| 10 | 1-4 | -0.141 | -0.148 | 0.685 | 0.815 |
| 11 | 0-4 | 0.384 | -0.375 | 0.398 | 0.838 |
| Item | F1 1 | F2 2 | F3 3 | h² 4 |
|---|---|---|---|---|
| 3 | 0.962 | -0.092 | 0.032 | 0.852 |
| 2 | 0.929 | -0.071 | 0.039 | 0.815 |
| 1 | 0.830 | 0.051 | 0.050 | 0.765 |
| 7 | 0.644 | 0.284 | -0.109 | 0.644 |
| 9 | 0.621 | -0.189 | -0.089 | 0.283 |
| 10 | 0.471 | 0.461 | -0.032 | 0.653 |
| 8 | -0.188 | 0.968 | -0.175 | 0.685 |
| 4 | 0.021 | 0.712 | 0.047 | 0.554 |
| 6 | -0.013 | 0.691 | 0.309 | 0.734 |
| 11 | 0.037 | -0.104 | 0.910 | 0.777 |
| 5 | -0.095 | 0.041 | 0.898 | 0.795 |
| % Explained Variance | 44.17 | 15.06 | 9.47 | - |
| Cronbach’s Alpha (α) | 0.85 | 0.73 | 0.75 | - |
| Variable | Min | Max | Mean | SD |
|---|---|---|---|---|
| ACRIS-CS Total Score | 34 | 100 | 67.36 | 12.10 |
| F1 - Affective attitude and effectiveness | 42 | 100 | 75.43 | 13.41 |
| F2 - Perceived benefits and self-efficacy | 17 | 100 | 63.20 | 16.10 |
| F3 - Perceived burden | 0 | 100 | 49.35 | 20.75 |
| r | p | |
| Age | 0.048 | 0.556 |
| Sex 1 | 0.111 | 0.171 |
| Education level 2 | 0.069 | 0.395 |
| Survival time | -0.073 | 0.371 |
| Treatment status 3 | -0.259 | 0.001 |
| Psychological counselling history 4 | 0.035 | 0.666 |
| Psychotropic medication use 5 | 0.072 | 0.372 |
| Perceived cognitive impairment | -0.093 | 0.318 |
| Anxiety | -0.051 | 0.588 |
| Depression | -0.045 | 0.631 |
| Knowledge of CRCI 6 | 0.251 | 0.002 |
| Independent Variables | B | β | 95%CI | t | p |
| Treatment status (completed treatments = 1) | -2.636 | -0.248 | -4.234; -1.039 | -3.26 | 0.001 |
| Knowledge of CRCI (yes = 1) | 2.598 | 0.240 | 0.970; 4.227 | 3.15 | 0.002 |
| F, p | 10.736, p < 0.001 | ||||
| R² adjusted | 0.113 | ||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).